Deciphering the transcriptomic landscape of early HR+/HER2- breast cancer in very young women.

Saved in:
Bibliographic Details
Title: Deciphering the transcriptomic landscape of early HR+/HER2- breast cancer in very young women.
Authors: Garrido-Cano I; Biomedical Research Institute INCLIVA, Valencia, Spain.; Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Valencia, Spain.; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Valencia, Spain., Tapia M; Medical Oncology Department, Hospital Clínico Universitario of Valencia, Valencia, Spain., Carbonell J; Biomedical Research Institute INCLIVA, Valencia, Spain., Peña C; Biomedical Research Institute INCLIVA, Valencia, Spain., Torres-Ruiz S; Biomedical Research Institute INCLIVA, Valencia, Spain., Ágreda-Roca A; Biomedical Research Institute INCLIVA, Valencia, Spain., Lameirinhas A; Biomedical Research Institute INCLIVA, Valencia, Spain., Tebar C; Biomedical Research Institute INCLIVA, Valencia, Spain., Burgués O; Biomedical Research Institute INCLIVA, Valencia, Spain.; Medical Oncology Department, Hospital Clínico Universitario of Valencia, Valencia, Spain.; Pathology Department, Hospital Clínico Universitario of Valencia, Valencia, Spain., Hernando C; Biomedical Research Institute INCLIVA, Valencia, Spain.; Medical Oncology Department, Hospital Clínico Universitario of Valencia, Valencia, Spain., Lluch A; Biomedical Research Institute INCLIVA, Valencia, Spain.; Department of Medicine, Universitat de València, Valencia, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), Valencia, Spain., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute, Barcelona, Spain.; Institute of Cancer and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapies in Solid Tumors Group, August Pi I Sunyer Biomedical Research Institute, Barcelona, Spain.; Institute of Cancer and Blood Disorders, Hospital Clinic of Barcelona, Barcelona, Spain., Bermejo B; Biomedical Research Institute INCLIVA, Valencia, Spain.; Medical Oncology Department, Hospital Clínico Universitario of Valencia, Valencia, Spain.; Department of Medicine, Universitat de València, Valencia, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), Valencia, Spain., Martínez MT; Biomedical Research Institute INCLIVA, Valencia, Spain.; Medical Oncology Department, Hospital Clínico Universitario of Valencia, Valencia, Spain., Cejalvo JM; Biomedical Research Institute INCLIVA, Valencia, Spain.; Medical Oncology Department, Hospital Clínico Universitario of Valencia, Valencia, Spain.; Center for Biomedical Network Research on Cancer (CIBERONC), Valencia, Spain.
Source: Cancer communications (London, England) [Cancer Commun (Lond)] 2025 Jul; Vol. 45 (7), pp. 789-793. Date of Electronic Publication: 2025 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2523-3548 (Electronic) Linking ISSN: 25233548 NLM ISO Abbreviation: Cancer Commun (Lond) Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first